Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara Anasti

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Virology|September 16, 2011
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationS Munir Alam, Hua-Xin Liao, S Moses Dennison, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Plos One|May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrumJames Friedman, S Munir Alam, Xiaoying Shen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Anti-HIV-1 B cell antigen receptor signaling and structureBhishem Thakur, Jahangir Alam, Kenneth Cronin, et al.
Cell Reports|June 29, 2022
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association ratesMd Alamgir Hossain, Kara Anasti, Brian Watts, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkGenevieve G Fouda, Frederick H Jaeger, Joshua D Amos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsS Munir Alam, S Moses Dennison, Baptiste Aussedat, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Kara Anasti, et al.
AIDS Research and Human Retroviruses|March 19, 2017
HIV-1 Consensus Envelope-Induced Broadly Binding AntibodiesR Ryan Meyerhoff, Richard M Scearce, Damon F Ogburn, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Virology|September 16, 2011
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationS Munir Alam, Hua-Xin Liao, S Moses Dennison, et al.
Journal of the American Chemical Society|August 7, 2013
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccinesBaptiste Aussedat, Yusuf Vohra, Peter K Park, et al.
Plos One|May 25, 2012
Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrumJames Friedman, S Munir Alam, Xiaoying Shen, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Anti-HIV-1 B cell antigen receptor signaling and structureBhishem Thakur, Jahangir Alam, Kenneth Cronin, et al.
Cell Reports|June 29, 2022
B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association ratesMd Alamgir Hossain, Kara Anasti, Brian Watts, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkGenevieve G Fouda, Frederick H Jaeger, Joshua D Amos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestorsS Munir Alam, S Moses Dennison, Baptiste Aussedat, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Kara Anasti, et al.
AIDS Research and Human Retroviruses|March 19, 2017
HIV-1 Consensus Envelope-Induced Broadly Binding AntibodiesR Ryan Meyerhoff, Richard M Scearce, Damon F Ogburn, et al.
Plos Pathogens|June 20, 2024
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functionsCamille N Pierre, Lily E Adams, Jaclyn S Higgins, et al.
Pageof 4